|
Volumn 47, Issue 6, 2001, Pages 855-861
|
Comparable aciclovir exposure produced by oral valaciclovir and intravenous aciclovir in immunocompromised cancer patients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACICLOVIR;
VALACICLOVIR;
ANTIVIRUS AGENT;
DRUG DERIVATIVE;
VALINE;
ADULT;
AGE;
AGED;
AREA UNDER THE CURVE;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER PATIENT;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONFUSION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG EXPOSURE;
DRUG HALF LIFE;
DRUG INFUSION;
DRUG MEGADOSE;
DRUG SAFETY;
EVALUATION;
FEMALE;
HALLUCINATION;
HEALTH CARE COST;
HEALTH INSURANCE;
HOSPITALIZATION;
HUMAN;
IMMUNE DEFICIENCY;
KIDNEY FUNCTION;
LEUKOCYTE COUNT;
MALE;
MICROANGIOPATHY;
MULTICENTER STUDY;
NEPHROTOXICITY;
NEUTROPENIA;
NEUTROPHIL;
PARAMETER;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
SIDE EFFECT;
STEADY STATE;
TIME;
ADOLESCENT;
HERPES SIMPLEX;
INTRAVENOUS DRUG ADMINISTRATION;
METABOLISM;
MIDDLE AGED;
NEOPLASM;
OPPORTUNISTIC INFECTION;
ORAL DRUG ADMINISTRATION;
VIROLOGY;
ACYCLOVIR;
ADMINISTRATION, ORAL;
ADOLESCENT;
ADULT;
AGED;
ANTIVIRAL AGENTS;
FEMALE;
HERPES SIMPLEX;
HUMANS;
IMMUNOCOMPROMISED HOST;
INFUSIONS, INTRAVENOUS;
MALE;
MIDDLE AGED;
NEOPLASMS;
OPPORTUNISTIC INFECTIONS;
VALINE;
|
EID: 0034743782
PISSN: 03057453
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (55)
|
References (26)
|